Cytokinetics Total Assets vs Total Liabilities Analysis

CYTK
 Stock
  

USD 53.69  1.87  3.61%   

Cytokinetics financial indicator trend analysis is way more than just evaluating Cytokinetics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cytokinetics is a good investment. Please check the relationship between Cytokinetics Total Assets and its Total Liabilities accounts. Continue to Trending Equities.

Total Assets vs Total Liabilities

Total Assets vs Total Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cytokinetics Total Assets account and Total Liabilities. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Cytokinetics' Total Assets and Total Liabilities is 0.98. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Liabilities in the same time period over historical financial statements of Cytokinetics, assuming nothing else is changed. The correlation between historical values of Cytokinetics' Total Assets and Total Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Cytokinetics are associated (or correlated) with its Total Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liabilities has no effect on the direction of Total Assets i.e., Cytokinetics' Total Assets and Total Liabilities go up and down completely randomly.

Correlation Coefficient

0.98
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Assets

Total assets refers to the total amount of Cytokinetics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cytokinetics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; [Intangibles]; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.

Total Liabilities

Deferred Income Tax is recorded on Cytokinetics balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Cytokinetics books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; Deferred Revenue; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most indicators from Cytokinetics fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cytokinetics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Continue to Trending Equities.Cytokinetics Selling General and Administrative Expense is increasing as compared to previous years. The last year's value of Selling General and Administrative Expense was reported at 96.8 Million. The current Issuance Purchase of Equity Shares is estimated to increase to about 345.2 M, while Enterprise Value over EBITDA is projected to decrease to (20.81) .
 2019 2020 2021 2022 (projected)
Revenues USD26.87 M55.83 M70.43 M59.29 M
Revenues26.87 M55.83 M70.43 M59.29 M

Cytokinetics fundamental ratios Correlations

0.960.910.810.990.540.920.980.920.690.890.850.760.970.860.890.850.961.00.82
0.960.970.910.980.650.980.980.980.80.850.940.870.980.950.930.941.00.970.74
0.910.970.980.950.720.970.920.970.840.860.990.950.950.980.910.980.970.920.73
0.810.910.980.860.770.930.840.930.860.80.990.980.880.980.870.980.910.830.65
0.990.980.950.860.590.960.980.960.740.880.90.810.980.910.910.890.981.00.8
0.540.650.720.770.590.60.580.590.460.680.680.680.590.690.740.680.650.560.34
0.920.980.970.930.960.60.941.00.870.780.970.920.960.980.880.970.980.930.73
0.980.980.920.840.980.580.940.930.730.860.870.780.970.880.930.860.980.980.82
0.920.980.970.930.960.591.00.930.870.770.970.920.960.980.870.970.980.930.72
0.690.80.840.860.740.460.870.730.870.480.890.890.830.910.690.920.80.70.57
0.890.850.860.80.880.680.780.860.770.480.780.710.820.760.870.730.850.90.79
0.850.940.990.990.90.680.970.870.970.890.780.990.920.990.850.990.940.860.66
0.760.870.950.980.810.680.920.780.920.890.710.990.850.970.790.980.870.770.57
0.970.980.950.880.980.590.960.970.960.830.820.920.850.940.890.930.980.970.77
0.860.950.980.980.910.690.980.880.980.910.760.990.970.940.871.00.950.870.66
0.890.930.910.870.910.740.880.930.870.690.870.850.790.890.870.840.930.90.75
0.850.940.980.980.890.680.970.860.970.920.730.990.980.931.00.840.940.860.65
0.961.00.970.910.980.650.980.980.980.80.850.940.870.980.950.930.940.970.74
1.00.970.920.831.00.560.930.980.930.70.90.860.770.970.870.90.860.970.82
0.820.740.730.650.80.340.730.820.720.570.790.660.570.770.660.750.650.740.82
Click cells to compare fundamentals

Cytokinetics Account Relationship Matchups

Cytokinetics fundamental ratios Accounts

201720182019202020212022 (projected)
Accounts Payable5.25 M3.76 M8.16 M8.05 M21.09 M22.75 M
Accumulated Other Comprehensive Income137 K343 K500 K679 K(869 K)(891.87 K)
Total Assets294.81 M211.18 M289.81 M533.8 M841.32 M907.74 M
Current Assets274.3 M207.67 M233.75 M474.22 M535.67 M577.96 M
Assets Non Current20.52 M3.5 M56.06 M59.58 M305.65 M329.78 M
Cash and Equivalents125.21 M42.26 M36.43 M82.98 M112.67 M91.18 M
Cash and Equivalents USD125.21 M42.26 M36.43 M82.98 M112.67 M91.18 M
Total Debt31.78 M43.18 M136.07 M138.94 M269.93 M291.24 M
Debt Non Current31.78 M40.58 M131.45 M136.15 M255.07 M275.2 M
Total Debt USD31.78 M43.18 M136.07 M138.94 M269.93 M291.24 M
Deferred Revenue20.86 M23.06 M24.57 M87 M100.05 M107.95 M
Shareholders Equity109.84 M25.93 M(10.94 M)113.38 M243.86 M263.12 M
Shareholders Equity USD109.84 M25.93 M(10.94 M)113.38 M243.86 M263.12 M
Investments160.2 M156.47 M231.33 M418.03 M511.02 M551.37 M
Investments Current143.69 M156.47 M188.68 M381.07 M358.97 M387.31 M
Investments Non Current7.67 M16.52 M42.65 M36.95 M152.05 M164.05 M
Total Liabilities184.97 M185.24 M300.75 M420.42 M597.46 M644.62 M
Current Liabilities32.44 M22.19 M26.02 M31.2 M71.86 M77.53 M
Liabilities Non Current152.52 M163.05 M274.73 M389.22 M525.6 M567.09 M
Trade and Non Trade Payables5.25 M3.76 M8.16 M8.05 M21.09 M22.75 M
Property Plant and Equipment Net3.57 M3.5 M13.41 M16.27 M146.41 M157.97 M
Trade and Non Trade Receivables1.11 M2.23 M5.16 M4.42 M51.82 M55.91 M
Accumulated Retained Earnings Deficit(646.08 M)(743.32 M)(865.02 M)(992.31 M)(1.21 B)(1.24 B)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cytokinetics without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Pair Trading with Cytokinetics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytokinetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytokinetics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cytokinetics

0.64BLUBellus Health Earnings Call  TomorrowPairCorr
The ability to find closely correlated positions to Cytokinetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytokinetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytokinetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytokinetics to buy it.
The correlation of Cytokinetics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytokinetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytokinetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytokinetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.4 B
Quarterly Revenue Growth YOY
30.29
Return On Assets
-0.17
Return On Equity
-3.38
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.